Subtopic Deep Dive

← Bacterial Identification and Susceptibility Testing

Rapid Antimicrobial Susceptibility Testing Methods
Research Guide

What is Rapid Antimicrobial Susceptibility Testing Methods?

Rapid Antimicrobial Susceptibility Testing Methods are diagnostic techniques that determine bacterial antibiotic resistance within hours using phenotypic assays like flow cytometry or genotypic predictions from genome sequences.

These methods reduce traditional 24-48 hour turnaround times from broth microdilution. Key approaches include Raman spectroscopy (Ho et al., 2019, 757 citations), genome-based predictions (Bradley et al., 2015, 574 citations), and MALDI-TOF MS (Huang et al., 2013, 500 citations). Over 10 papers from 2013-2019 exceed 400 citations each.

Curated Papers

Key Challenges

Why It Matters

Rapid AST enables same-day therapy adjustments, reducing mortality from bacteremia by optimizing antibiotics sooner (Huang et al., 2013). In carbapenemase outbreaks, genotypic prediction from sequences predicts resistance for Staphylococcus aureus and Mycobacterium tuberculosis (Bradley et al., 2015; Bonomo et al., 2017). EUCAST guidelines highlight whole genome sequencing's role in clinical labs facing resistance threats (Ellington et al., 2016; CDC, 2019).

Key Research Challenges

Accuracy of Genotypic Prediction

Genomic methods predict resistance from mutations but miss phenotypic expression variations (Bradley et al., 2015). EUCAST notes gaps in non-model organisms (Ellington et al., 2016). Clinical validation lags behind sequencing speed.

Standardization Across Platforms

Phenotypic rapid tests like flow cytometry vary by device and protocol (Baron et al., 2013). MALDI-TOF integration requires stewardship to impact outcomes (Huang et al., 2013). Inter-lab reproducibility remains inconsistent.

Clinical Turnaround Integration

Blood culture-based rapid ID shortens detection but AST lags (Opota et al., 2015). Real-world implementation faces workflow hurdles despite lab efficacy (Baron et al., 2013). Cost-effectiveness data is limited.

Essential Papers

Antibiotic resistance threats in the United States, 2019

Centers for Disease Control and Prevention (U.S.) · 2019 · 5.8K citations

This report is dedicated to the 48,700 families who lose a loved one each year to antibiotic resistance or Clostridioides difficile, and the countless healthcare providers, public health experts, i...

Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning

Chi-Sing Ho, Neal Jean, Catherine A. Hogan et al. · 2019 · Nature Communications · 757 citations

Carbapenemase-Producing Organisms: A Global Scourge

Robert A. Bonomo, Eileen M. Burd, John Conly et al. · 2017 · Clinical Infectious Diseases · 605 citations

The dramatic increase in the prevalence and clinical impact of infections caused by bacteria producing carbapenemases is a global health concern. Carbapenemase production is especially problematic ...

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a

Ellen Jo Baron, Miller Jm, Melvin P. Weinstein et al. · 2013 · Clinical Infectious Diseases · 584 citations

Abstract The critical role of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician and the microbiologists who provide ...

Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis

Phelim Bradley, N Claire Gordon, A Sarah Walker et al. · 2015 · Nature Communications · 574 citations

The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee

M.J. Ellington, Oskar Ekelund, Frank M. Aarestrup et al. · 2016 · Clinical Microbiology and Infection · 545 citations

Advances in Chemical and Biological Methods to Identify Microorganisms—From Past to Present

Ricardo Franco‐Duarte, Lucia Černáková, Snehal Kadam et al. · 2019 · Microorganisms · 510 citations

Fast detection and identification of microorganisms is a challenging and significant feature from industry to medicine. Standard approaches are known to be very time-consuming and labor-intensive (...

Reading Guide

Foundational Papers

Start with Baron et al. (2013, 584 citations) for lab guidelines and Huang et al. (2013, 500 citations) for MALDI-TOF clinical impact, establishing rapid ID-AST workflows.

Recent Advances

Study Bradley et al. (2015, 574 citations) and Ellington et al. (2016, 545 citations) for genomic AST; Ho et al. (2019, 757 citations) for spectroscopy advances.

Core Methods

Core techniques: genome sequence resistance prediction (Bradley et al., 2015), MALDI-TOF with stewardship (Huang et al., 2013), Raman deep learning (Ho et al., 2019), per EUCAST WGS rules (Ellington et al., 2016).

How PapersFlow Helps You Research Rapid Antimicrobial Susceptibility Testing Methods

Discover & Search

Research Agent uses searchPapers and exaSearch to find 50+ papers on rapid AST, starting with Bradley et al. (2015) via citationGraph to map genotypic prediction networks. findSimilarPapers expands to Raman and MALDI-TOF methods like Ho et al. (2019).

Analyze & Verify

Analysis Agent applies readPaperContent to extract turnaround times from Huang et al. (2013), then verifyResponse with CoVe checks claims against Ellington et al. (2016). runPythonAnalysis parses resistance prediction accuracies from Bradley et al. (2015) into pandas tables; GRADE grades evidence as high for mortality reduction.

Synthesize & Write

Synthesis Agent detects gaps in phenotypic-genotypic concordance, flagging contradictions between Ho et al. (2019) and Bonomo et al. (2017). Writing Agent uses latexEditText for methods sections, latexSyncCitations for 20+ refs, and latexCompile for full reviews; exportMermaid diagrams AST workflow comparisons.

Use Cases

"Compare accuracy of genomic vs phenotypic rapid AST for S. aureus"

Research Agent → searchPapers + citationGraph (Bradley 2015 hub) → Analysis Agent → runPythonAnalysis (extract metrics to CSV) → outputs accuracy table with 92% genomic sensitivity.

"Generate LaTeX review of MALDI-TOF AST impact on bacteremia"

Synthesis Agent → gap detection (Huang 2013) → Writing Agent → latexEditText + latexSyncCitations + latexCompile → researcher gets compiled PDF with figures.

"Find open-source code for Raman spectroscopy AST models"

Research Agent → paperExtractUrls (Ho 2019) → Code Discovery → paperFindGithubRepo + githubRepoInspect → researcher gets inspected Python repos with deep learning models.

Automated Workflows

Deep Research workflow scans 50+ AST papers via searchPapers → DeepScan with 7-step CoVe verifies claims from Baron et al. (2013) → structured report on clinical utility. Theorizer generates hypotheses on integrating Raman (Ho et al., 2019) with WGS (Ellington et al., 2016) for hybrid rapid AST.

Try Doxa for Rapid Antimicrobial Susceptibility Testing Methods Research

Frequently Asked Questions

What defines rapid AST?

Techniques achieving susceptibility results in under 6 hours via phenotypic (flow cytometry) or genotypic (sequence prediction) means, versus 24+ hours traditionally.

What are main methods?

Phenotypic: MALDI-TOF (Huang et al., 2013), Raman spectroscopy (Ho et al., 2019); genotypic: WGS resistance prediction (Bradley et al., 2015; Ellington et al., 2016).

What are key papers?

Bradley et al. (2015, 574 citations) on genomic predictions; Huang et al. (2013, 500 citations) on MALDI-TOF outcomes; Ho et al. (2019, 757 citations) on Raman ID.

What are open problems?

Standardizing genotypic-phenotypic correlations (Ellington et al., 2016), scaling to non-cultured samples, and proving cost savings in stewardship (Baron et al., 2013).